Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are undergoing a lung transplant and have been diagnosed with COPD (a chronic lung condition) or pulmonary fibrosis (scarring of the lungs), with or without also having pulmonary hypertension (high blood pressure in the lungs).
- Outpatients (people receiving care without being admitted to hospital) who have been diagnosed with COPD or pulmonary fibrosis, with or without also having pulmonary hypertension.
Who may not be able to join:
- People who have been diagnosed with other lung diseases not mentioned above.
- People who show signs of an active infection, such as pneumonia, tuberculosis affecting the lungs, or fluid build-up around the lungs.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nikolaus Kneidinger, MD, Medical University of Graz
Phone: 004331638572918
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Analysis of collagen fragments
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.